Danie Theron
Overview
Explore the profile of Danie Theron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tzelios C, Malatesta S, Carney T, White L, Weber S, Thomson S, et al.
Clin Infect Dis
. 2025 Feb;
PMID: 39973802
Background: Adverse drug reactions (ADRs) to tuberculosis (TB) medications make treatment completion challenging. We investigated the impact of alcohol, human immunodeficiency virus (HIV), and other patient determinants on ADRs and...
2.
Overbeck V, Malatesta S, Carney T, Myers B, Parry C, Horsburgh C, et al.
BMC Infect Dis
. 2024 Oct;
24(1):1154.
PMID: 39396938
Background: The COVID-19 pandemic negatively impacted tuberculosis (TB) treatment services, including directly observed therapy (DOT) programs used to promote medication adherence. We compared DOT adherence embedded in a research study...
3.
Kulkarni S, Weber S, Buys C, Lambrechts T, Myers B, Drainoni M, et al.
BMC Public Health
. 2024 Aug;
24(1):2216.
PMID: 39143513
Background: Unhealthy alcohol use is widespread in South Africa and has been linked to tuberculosis (TB) disease and poor treatment outcomes. This study used qualitative methods to explore the relationship...
4.
Kulkarni S, Weber S, Buys C, Lambrechts T, Myers B, Drainoni M, et al.
Res Sq
. 2023 Oct;
PMID: 37841852
Background: Unhealthy alcohol use is widespread in South Africa and has been linked to tuberculosis (TB) disease and poor treatment outcomes. This study used qualitative methods to explore the relationship...
5.
Malatesta S, Weir I, Weber S, Bouton T, Carney T, Theron D, et al.
BMC Med Res Methodol
. 2022 Nov;
22(1):297.
PMID: 36402979
Background: The occurrence and timing of mycobacterial culture conversion is used as a proxy for tuberculosis treatment response. When researchers serially sample sputum during tuberculosis studies, contamination or missed visits...
6.
Carney T, Rooney J, Niemand N, Myers B, Theron D, Wood R, et al.
PLoS One
. 2022 Feb;
17(2):e0262440.
PMID: 35167586
People who use illicit drugs (PWUDs) have been identified as a key at-risk group for tuberculosis (TB). Examination of illicit drug use networks has potential to assess the risk of...
7.
Bouton T, De Vos M, Ragan E, White L, Van Zyl L, Theron D, et al.
PLoS One
. 2019 Oct;
14(10):e0223308.
PMID: 31622366
South Africa led the world with guidelines on bedaquiline (BDQ) use as a single drug substitution to manage rifampin resistant tuberculosis regimen toxicity. We examined reasons for giving BDQ in...
8.
Myers B, Bouton T, Ragan E, White L, McIlleron H, Theron D, et al.
BMC Infect Dis
. 2018 Oct;
18(1):488.
PMID: 30268101
Background: An estimated 10% of tuberculosis (TB) deaths are attributable to problematic alcohol use globally, however the causal pathways through which problem alcohol use has an impact on TB treatment...
9.
Kendall E, Theron D, Franke M, van Helden P, Victor T, Murray M, et al.
PLoS One
. 2013 Dec;
8(12):e83480.
PMID: 24349518
Background: Default from multidrug-resistant tuberculosis (MDR-TB) treatment remains a major barrier to cure and epidemic control. We sought to identify patient risk factors for default from MDR-TB treatment and high-risk...
10.
Jacobson K, Theron D, Kendall E, Franke M, Barnard M, van Helden P, et al.
Clin Infect Dis
. 2012 Oct;
56(4):503-8.
PMID: 23090928
Background: Diagnosis of drug resistance and timely initiation of multidrug-resistant (MDR) tuberculosis therapy are essential to reduce transmission and improve patient outcomes. We sought to determine whether implementation of the...